Medical device with sponge coating for controlled drug release

• US 7,462,165 B2
• Filed: 02/07/2002
• Issued: 12/09/2008
• Est. Priority Date: 04/14/1998
• Status: Expired due to Fees

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Ding, Ni, Andrus, W. Scott
• Primary Examiner(s): Lucchesi; Nicholas D.
• Assistant Examiner(s): Stigell; Theodore J
• Application Number:
  US10/071,400
• Publication Number:
  US 20020082552A1
• Time in Patent Office: 2,497 Days
• Field of Search: 604/96, 604/96.01, 604/93.01, 604 9901- 9904, 60410101-10105, 604/103, 60410301-10303, 6041035-10308, 604/103.11, 60410312-10315, 604104-109, 604/509, 604/265, 604/266, 604/532, 604285-287, 604/913, 604/920, 623/1.11, 623/1.12, 427/2.1, 427/2.12, 427/2.13, 427/2.22, 427/2.24, 427/2.25, 427/2.3
• US Class Current: 604/103.02
• CPC Class Codes: A61F 2/86 Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
• CPC Class Codes: A61F 2250/0068 the pharmaceutical product being in a reservoir
• CPC Class Codes: A61L 2300/236 Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
• CPC Class Codes: A61L 2300/42 Anti-thrombotic agents, anticoagulants, anti-platelet agents
• CPC Class Codes: A61L 2300/606 Coatings
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61M 2025/105 having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
• CPC Class Codes: A61M 2025/1075 having a balloon composed of several layers, e.g. by coating or embedding
• CPC Class Codes: A61M 2025/1081 having sheaths or the like for covering the balloon but not forming a permanent part of the balloon, e.g. retractable, dissolvable or tearable sheaths
• CPC Class Codes: A61M 25/104 used for angioplasty

Abstract

The medical devices of the invention comprise an expandable portion which is covered with a sponge coating for release of at least one biologically active material. The sponge coating is made of a non-hydrogel polymer having a plurality of voids. The device can further include means for infusing or expelling the biologically active material or drug into the voids. The drug is delivered to the body lumen of a patient by expelling the drug and inflating or expanding the expandable portion of the catheter or device.

Claims

1. A catheter for delivering a biologically active material to a desired location of a body lumen of a patient comprising an expandable portion which is insertable or implantable into a body lumen, wherein the expandable portion is expandable in response to inflation pressure to fill the cross-section of the lumen and engage the tissue of the lumen and wherein the expandable portion comprises:

a) a balloon having an outer surface;

b) a membrane having a plurality of pores therein wherein the membrane comprises an outer surface and an inner surface, wherein the membrane is disposed about the balloon;

c) a reservoir space disposed between the outer surface of the balloon, and the inner surface of the membrane and wherein the reservoir space is connected to a reservoir lumen for filling the reservoir space with the biologically active material; and

d) a biostable sponge coating disposed upon the outer surface of the membrane wherein the sponge coating is exposed to the body lumen when the catheter is inserted or implanted into the body lumen and, wherein the sponge coating comprises a non-hydrogel polymer having a plurality of voids and wherein the sponge coating is in fluid communication with the reservoir space such that the biologically active material when present in the reservoir space can pass through the pores of the membrane and enter the voids.

2. The catheter of claim 1 wherein the voids are formed by eluting a particulate material from the polymer.

3. The catheter of claim 1, wherein the void space of the sponge coating is greater than about 60% of the volume of the sponge coating.

4. The catheter of claim 1 further comprising an inflation lumen connected to the balloon.

5. The catheter of claim 1 wherein the polymer comprises an elastomer.

6. The catheter of claim 5 wherein the elastomer comprises a silicone, polyurethane, thermoplastic elastomer, ethylene vinyl acetate copolymer, polyolefin elastomer, or EPDM rubber.

7. The catheter of claim 1 wherein the biologically active material is heparin, paclitaxel, or rapamycin.